Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does ARIPIPRAZOLE Cause Type 2 diabetes mellitus? 233 Reports in FDA Database

Sharpen Your Memory & Focus Naturally

NeuroZoom — 35 clinically studied ingredients. No stimulants. Pure brain support.

Boost Your Brain

According to the FDA Adverse Event Reporting System (FAERS), 233 reports of Type 2 diabetes mellitus have been filed in association with ARIPIPRAZOLE (Aripiprazole). This represents 0.4% of all adverse event reports for ARIPIPRAZOLE.

233
Reports of Type 2 diabetes mellitus with ARIPIPRAZOLE
0.4%
of all ARIPIPRAZOLE reports
16
Deaths
84
Hospitalizations

How Dangerous Is Type 2 diabetes mellitus From ARIPIPRAZOLE?

Of the 233 reports, 16 (6.9%) resulted in death, 84 (36.1%) required hospitalization, and 6 (2.6%) were considered life-threatening.

Is Type 2 diabetes mellitus Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for ARIPIPRAZOLE. However, 233 reports have been filed with the FAERS database.

What Other Side Effects Does ARIPIPRAZOLE Cause?

Drug ineffective (5,566) Off label use (5,473) Product use in unapproved indication (4,792) Weight increased (4,636) Anxiety (3,076) Suicide attempt (2,796) Suicidal ideation (2,618) Condition aggravated (2,157) Insomnia (2,147) Akathisia (2,107)

What Other Drugs Cause Type 2 diabetes mellitus?

ATORVASTATIN (7,556) ADALIMUMAB (3,516) PREDNISONE (3,484) METHOTREXATE (3,465) RITUXIMAB (3,318) TOCILIZUMAB (3,145) ABATACEPT (3,074) LEFLUNOMIDE (3,033) ALENDRONATE (3,002) DICLOFENAC (2,974)

Which ARIPIPRAZOLE Alternatives Have Lower Type 2 diabetes mellitus Risk?

ARIPIPRAZOLE vs ARIPIPRAZOLE LAUROXIL ARIPIPRAZOLE vs ARIXTRA ARIPIPRAZOLE vs ARMODAFINIL ARIPIPRAZOLE vs AROMASIN ARIPIPRAZOLE vs ARSENIC TRIOXIDE

Related Pages

ARIPIPRAZOLE Full Profile All Type 2 diabetes mellitus Reports All Drugs Causing Type 2 diabetes mellitus ARIPIPRAZOLE Demographics